Technical Articles
UA040172
How to Choose TGF-β1: Activity Judgment and Arrival Acceptance Q&A
A selection guide for TGF-β1: judging activity data, arrival acceptance and supplier considerations for reproducible signaling experiments.
View details
- Signaling Pathway
- TGF-β1 selection
- activity judgment
- arrival acceptance
- supplier
- UA040172
What Is TGF-β1: Latent Activation Mechanism and Activity Determination Guide
TGF-β1 acts through a latent-complex activation mechanism. This article explains latency, activation and Smad signaling, and how to determine activity of recombinant TGF-β1.
View details
- Signaling Pathway
- TGF-β1
- latent activation
- Smad2/3
- activity determination
- recombinant TGF-β1
- UA040172
TGF-β1 in Translation: Fibrosis, Tumor Microenvironment and Drug Strategies
TGF-β1 sits at the center of fibrosis and immunosuppressive tumor microenvironment research. This article reviews ALK5 inhibitors, ligand traps and translational study design around TGF-β1.
View details
- Signaling Pathway
- TGF-β1 target
- ALK5 inhibitor
- ligand trap
- tumor microenvironment
- fibrosis
- immunosuppression
- UA040172
Working with TGF-β1: Stabilizing Cell-Treatment Activity Readouts
A practical guide to TGF-β1 cell treatment: low-concentration adsorption and carrier protein, phosphorylated Smad2/3 readouts, reporter assays and troubleshooting variable activity data.
View details
- Signaling Pathway
- TGF-β1 cell treatment
- adsorption
- carrier protein
- phospho-Smad2/3
- reporter assay
- troubleshooting
- UA040172
TGF-β1: Why the Latent Complex Guards Tissue Homeostasis
TGF-β1 is secreted in a latent complex with LAP and LTBP. This article explains latency and activation, Smad2/3 and ALK5 signaling, and its roles in EMT and fibrosis.
View details
- Signaling Pathway
- TGF-β1
- TGFB1
- latent complex
- LAP
- LTBP
- Smad2/3
- ALK5
- EMT
- fibrosis
- UA040172
- 1











